OncoTherapy Science, Inc. has entered into a license agreement with Societe d'Exploitation de Produits pour les Industries Chimiques S.A. (SEPPIC) to grant the exclusive rights to manufacture and sell the compact automatic emulsion-preparing devices originally developed by OncoTherapy. Under the terms of the agreement: OncoTherapy grants SEPPIC the exclusive rights to manufacture and sell the compact automatic emulsion-preparing devices; OncoTherapy will provide necessary information for such manufacture and sale to SEPPIC, and cooperate with SEPPIC; and OncoTherapy will receive royalty based on the sales amount of such devices in consideration of the licenses under this agreement.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23 JPY | +4.55% | +4.55% | 0.00% |
Apr. 29 | Poland's Tusk calls prosecutor over potential Orlen scandal | RE |
Apr. 22 | OncoTherapy Science, Inc. cancelled the transaction announced on April 5, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
0.00% | 36.26M | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+3.23% | 22.78B | |
-10.44% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- 4564 Stock
- News OncoTherapy Science, Inc.
- OncoTherapy Science, Inc. Signs Licensing Agreement with Societe d'Exploitation de Produits pour les Industries Chimiques S.A